Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-29T10:03:18.482Z Has data issue: false hasContentIssue false
  • English
  • Français

Ageing as a risk factor for lithium neurotoxicity at therapeutic serum levels

Published online by Cambridge University Press:  02 January 2018

Alastair Flint
Alastair Flint*
Affiliation:
Toronto General Hospital, Toronto Canada M5G 2C4
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 163 , Issue 4 , October 1993 , pp. 555 - 556
Copyright
Copyright © Royal College of Psychiatrists, 1993 

References

Austin, L. S., Arana, G. W. & Melvin, J. A. (1990) Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. Journal of Clinical Psychiatry, 51, 344–345.Google Scholar
Lafferman, J., Solomon, K. & Ruskin, P. (1988) Lithium augmentation for treatment-resistant depression the elderly. Journal of Geriatric Psychiatry and Neurology, 1, 49–52.CrossRefGoogle ScholarPubMed
Murray, N., Hopwood, S., Balfour, D. J. K., et al (1983) The influence of age on lithium efficacy and side-effects in outpatients. Psychological Medicine. 13, 53–60.CrossRefGoogle Scholar
Roose, S. P., Bone, S., Haidorfer, C., et al (1979) Lithium treatment in older patients. American Journal of Psychiatry, 136, 843–844.Google Scholar
Smith, R. E. & Helms, P. M. (1982) Adverse effects of lithium therapy in the acutely ill elderly patient. Journal of Clinical Psychiatry, 43, 94–99.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.